相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
Wenwen Chien et al.
MOLECULAR ONCOLOGY (2015)
Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
Feng Li et al.
ONCOTARGET (2015)
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential
Giorgio Cozza et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
L. R. Martins et al.
LEUKEMIA (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
Enhancing Chemotherapy Efficacy in Pten-Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity
Alberto Toso et al.
CELL REPORTS (2014)
CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data
Gabriela Bindea et al.
BIOINFORMATICS (2013)
Anticancer efficacy of cisplatin and trichostatin A 5-aza-2′-deoxycytidine on ovarian cancer
F. Meng et al.
BRITISH JOURNAL OF CANCER (2013)
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
Christian Tovar et al.
CANCER RESEARCH (2013)
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
JulieAnn Rader et al.
CLINICAL CANCER RESEARCH (2013)
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumueller et al.
NATURE (2013)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
CK2 Inhibitor CX-4945 Blocks TGF-β1-Induced Epithelial-to-Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cells
Jiyeon Kim et al.
PLOS ONE (2013)
Protein kinase CK2 inhibitors: a patent review
Giorgio Cozza et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis
Cristiane M. Furtado et al.
PLOS ONE (2012)
Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot et al.
BIOINFORMATICS (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
F. Peter Guengerich
DRUG METABOLISM AND PHARMACOKINETICS (2011)
Mechanistic Analysis of a DNA Damage-Induced, PTEN-Dependent Size Checkpoint in Human Cells
Jung-Sik Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Pro-senescence therapy for cancer treatment
Caterina Nardella et al.
NATURE REVIEWS CANCER (2011)
Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro
Hui Liu et al.
ANTI-CANCER DRUGS (2010)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
Andrea Alimonti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y
Ayhan Bilir et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
Fabienne Baffert et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Jinbo Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
Giorgio Cozza et al.
BIOCHEMICAL JOURNAL (2009)
Methotrexate-induced senescence in human adenocarcinoma cells is accompanied by induction of p21waf1/cip1 expression and lack of polyploidy
Magdalena Dabrowska et al.
CANCER LETTERS (2009)
Cellular functions of Protein kinase CK2: a dynamic affair
O. Filhol et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
CK2: A key player in cancer biology
J. H. Trembley et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Tumor immunobiological differences in prostate cancer between African-American and European-American men
Tiffany A. Wallace et al.
CANCER RESEARCH (2008)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor
P. P. Scaglioni et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells:: implication for targeted therapy
Tapas K. Sengupta et al.
MOLECULAR CANCER (2007)
Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening
Michael J. Orsini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Benzethonium chloride: A novel anticancer agent identified by using a cell-based small-molecule screen
Kenneth W. Yip et al.
CLINICAL CANCER RESEARCH (2006)
A CK2-dependent mechanism for degradation of the PML tumor suppressor
Pier Paolo Scaglioni et al.
CELL (2006)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
ZB Chen et al.
NATURE (2005)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
G Di Maira et al.
CELL DEATH AND DIFFERENTIATION (2005)
Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers
RS Roberson et al.
CANCER RESEARCH (2005)
Synthesis of phenazine derivatives for use as precursors to electrochemically generated bases
AM Alonso et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Loss of the tumor suppressor PML in human cancers of multiple histologic origins
C Gurrieri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme
K Niefind et al.
EMBO JOURNAL (2001)
Effect of nifedipine in metastatic colon cancer with DNA mismatch repair gene defect
JL Yang et al.
LANCET (2001)
Atmospheric carbon dioxide concentrations over the past 60 million years
PN Pearson et al.
NATURE (2000)
分享论文
